Article Information
History
- August 9, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Zoe O Demko1,
- Tong Yu1,
- Sarika K. Mullapudi1,
- M. Gabriela Varela Heslin1,
- Chamia A. Dorsey1,
- Christine B. Payton1,
- Jeffrey A. Tornheim1,
- Paul W. Blair1,2,
- Shruti H. Mehta3,
- David L. Thomas1,
- Yukari C. Manabe1,†,
- Annukka A.R. Antar1,#,
- the OutSMART Study Team*
- 1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- 2Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA
- 3Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
- ↵#Corresponding Author:
Annukka A. R. Antar, Assistant Professor, Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Ross Research Bldg Room 1064, 720 Rutland Ave, Baltimore, MD 21205, aantar1{at}jhmi.edu - ↵†Alternate Corresponding Author:
Yukari C. Manabe, Professor, Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, 1830 E Monument St Room 443, Baltimore, MD 21205, ymanabe{at}jhmi.edu
Posted August 09, 2022.
Post-acute sequelae of SARS-CoV-2 (PASC) impact quality of life at 6, 12 and 18 months post-infection
